Nicole D Fleming MD
Gynecologic Oncology
Deputy Chief Medical Officer and Professor, Fred Hutchinson Cancer Center Professor, Division of Gynecologic Oncology, University of Washington Medical Center
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-520-5000
Dr. Fleming is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nicole Fleming is a Gynecologic Oncologist in Seattle, WA and is affiliated with Fred Hutchinson Cancer Center and the University of Washington. She received her medical degree from McGovern Medical School at UTHealth and has been in practice 14 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology, gynecologic oncology, and minimally invasive gynecologic surgery. She has more than 75 publications and over 500 citings. She has held administrative positions as Center Medical Director at MD Anderson Sugar Land campus, Inpatient Medical Director for Gynecology services at MD Anderson hospital, Director of Surgery in the MD Anderson Cancer Network, and current role as the Deputy Chief Medical Officer for Fred Hutchinson Cancer Center at the South Lake Union Campus.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 2008 - 2011
Duke University HospitalResidency, Obstetrics and Gynecology, 2004 - 2008
McGovern Medical School at UTHealthClass of 2004
Certifications & Licensure
CA State Medical License 2008 - Present
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Adavosertib Before Surgery in Treating Patients with Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2016 Feb 04
Roles: Principal Investigator, Contact
- Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer Start of enrollment: 2015 Sep 23
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.Jeffrey A How, Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N Westin
Med. 2025-01-10 - The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvan...Roni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin, Bryan M Fellman, Travis T Sims
International Journal of Gynecological Cancer. 2025-01-06 - Comparative analysis of hormonal therapy in low-grade endometrial stromal sarcoma: A retrospective study.Reem Saab, Bryan M Fellman, Alejandra Flores Legarreta, Larissa A Meyer, Nicole D Fleming
Gynecologic Oncology. 2024-12-01
Journal Articles
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerShannon N Westin, Lois M Ramondetta, Kathleen M Schmeler, Pamela T Soliman, Nicole D Fleming, Jennifer K Burzawa, Alpa M Nick, Andrea M Milbourne, Diane C Bodurka, Rob..., American Journal of Obstetrics and Gynecology
Lectures
- Correlation of surgeon radiology assessment with laparoscopic scoring in patients with advanced-stage ovarian cancer.2019 ASCO Annual Meeting - 6/1/2019
- An Oncology Symposium For The Primary Care ProviderThe University of Texas, M. D. Anderson Cancer Center, Sugar Land, Texas - 9/29/2012
- 5th Symposium on Emerging Treatments & Advances in Novel Cancer Therapies for Practicing Physicians & Healthcare ProfessionalsCancerNet, LLC, Dallas, Texas - 1/18/2012
Authored Content
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
- Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
